Login to Your Account

Chiron Files Pulminiq NDA As Feds Probe Flu Vaccine Miscue

By Aaron Lorenzo

Friday, October 15, 2004
Releasing a bit of good news, Chiron Corp. submitted a new drug application for Pulminiq inhalation solution for lung transplant patients. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription